Dr. Succaria on Combination Immunotherapy in Head and Neck Cancer – OncLive
|
Dr. Succaria on Combination Immunotherapy in Head and Neck Cancer
OncLive In a study of the tumor microenvironment of head and neck squamous cell carcinoma (SCCHN), investigators were interested in the effects of combination immunotherapy. Monotherapy with checkpoint inhibition has previously shown efficacy in head and … |
